FDA Approves Durvalumab-Chemo Combo for Resectable NSCLC
The approval was based on trial results which showed the regimen reduced the risk of recurrence, progression, or death by 32% versus neoadjuvant chemotherapy alone.
Tag: chemotherapy
All
Latest
All
Latest
FDA Approves Medication to Prevent Chemo Damage in Lung Cancer
The FDA approved the new medication Cosela for injection to decrease the damage to the immune system and bone marrow from chemotherapy administered for lung cancer.
